These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8076359)

  • 1. Potentiation of ricin A immunotoxin by monoclonal antibody targeted monensin containing small unilamellar vesicles.
    Singh M; Griffin T; Salimi A; Micetich RG; Atwal H
    Cancer Lett; 1994 Aug; 84(1):15-21. PubMed ID: 8076359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T; Raso V
    Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of antitumor immunotoxins by liposomal monensin.
    Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
    J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of monensin PLGA polymer nanoparticles and liposomes as potentiator of ricin A immunotoxins in vitro.
    Ferdous AJ; Stembridge NY; Singh M
    J Control Release; 1998 Jan; 50(1-3):71-8. PubMed ID: 9685874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of anti-My9 antibody to stealth monensin liposomes and the effect of conjugated liposomes on the cytotoxicity of immunotoxin.
    Sudhan Shaik M; Kanikkannan N; Singh M
    J Control Release; 2001 Oct; 76(3):285-95. PubMed ID: 11578743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo potentiation of ricin toxicity by monensin delivered through liposomes.
    Vasandani VM; Madan S; Ghosh PC
    Biochim Biophys Acta; 1992 Jun; 1116(3):315-23. PubMed ID: 1377030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
    Griffin TW; Pagnini PG; Houston LL
    J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs.
    Shaik MS; Ikediobi O; Turnage VD; McSween J; Kanikkannan N; Singh M
    J Pharm Pharmacol; 2001 May; 53(5):617-27. PubMed ID: 11370701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
    Recht LD; Griffin TW; Raso V; Salimi AR
    Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stealth monensin immunoliposomes as potentiator of immunotoxins in vitro.
    Singh M; Ferdous AJ; Kanikkannan N; Faulkner G
    Eur J Pharm Biopharm; 2001 Jul; 52(1):13-20. PubMed ID: 11438419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
    Ramakrishnan S; Bjorn MJ; Houston LL
    Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of ricin toxin A chain immunotoxin activity: synthesis, ionophoretic ability, and in vitro activity of monensin derivatives.
    Dosio F; Franceschi A; Ceruti M; Brusa P; Cattel L; Colombatti M
    Biochem Pharmacol; 1996 Jul; 52(1):157-66. PubMed ID: 8678901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
    Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
    J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates.
    Candiani C; Franceschi A; Chignola R; Pasti M; Anselmi C; Benoni G; Tridente G; Colombatti M
    Cancer Res; 1992 Feb; 52(3):623-30. PubMed ID: 1732050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of monensin liposomes on the cytotoxicity of anti-My9-bR immunotoxin.
    Shaik MS; Jackson TL; Singh M
    J Pharm Pharmacol; 2003 Jun; 55(6):819-25. PubMed ID: 12841943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: effect of monensin intercalated into folate-tagged liposomes.
    Tyagi N; Ghosh PC
    Eur J Pharm Sci; 2011 Jul; 43(4):343-53. PubMed ID: 21621613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion molecule.
    Derbyshire EJ; Stahel RA; Wawrzynczak EJ
    Clin Exp Immunol; 1992 Sep; 89(3):336-40. PubMed ID: 1325302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
    Derbyshire EJ; Henry RV; Stahel RA; Wawrzynczak EJ
    Br J Cancer; 1992 Sep; 66(3):444-51. PubMed ID: 1325825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monensin intercalation in liposomes: effect on cytotoxicities of ricin, Pseudomonas exotoxin A and diphtheria toxin in CHO cells.
    Madan S; Ghosh PC
    Biochim Biophys Acta; 1992 Sep; 1110(1):37-44. PubMed ID: 1390834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancer.
    Derbyshire EJ; Wawrzynczak EJ
    Int J Cancer; 1992 Oct; 52(4):624-30. PubMed ID: 1328073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.